- Home
- MCRB vs UNB Comparison
MCRB vs UNB Comparison
Compare MCRB & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- UNB
- Stock Information
- Founded
- MCRB 2010
- UNB 1891
- Country
- MCRB United States
- UNB United States
- Employees
- MCRB N/A
- UNB N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- UNB Major Banks
- Sector
- MCRB Health Care
- UNB Finance
- Exchange
- MCRB Nasdaq
- UNB Nasdaq
- Market Cap
- MCRB 141.9M
- UNB 167.6M
- IPO Year
- MCRB 2015
- UNB 1998
- Fundamental
- Price
- MCRB $0.37
- UNB $31.34
- Analyst Decision
- MCRB Hold
- UNB
- Analyst Count
- MCRB 5
- UNB 0
- Target Price
- MCRB $4.00
- UNB N/A
- AVG Volume (30 Days)
- MCRB 1.3M
- UNB 11.7K
- Earning Date
- MCRB 05-07-2025
- UNB 05-13-2025
- Dividend Yield
- MCRB N/A
- UNB 4.63%
- EPS Growth
- MCRB N/A
- UNB N/A
- EPS
- MCRB 0.00
- UNB 1.92
- Revenue
- MCRB N/A
- UNB $47,157,000.00
- Revenue This Year
- MCRB N/A
- UNB N/A
- Revenue Next Year
- MCRB N/A
- UNB N/A
- P/E Ratio
- MCRB $474.36
- UNB $16.32
- Revenue Growth
- MCRB N/A
- UNB N/A
- 52 Week Low
- MCRB $0.46
- UNB $21.00
- 52 Week High
- MCRB $1.53
- UNB $37.70
- Technical
- Relative Strength Index (RSI)
- MCRB 28.34
- UNB 58.70
- Support Level
- MCRB $0.36
- UNB $28.00
- Resistance Level
- MCRB $0.67
- UNB $29.32
- Average True Range (ATR)
- MCRB 0.07
- UNB 1.31
- MACD
- MCRB -0.02
- UNB 0.18
- Stochastic Oscillator
- MCRB 2.71
- UNB 78.91
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group. Geographically, all the business activity is functioned through the United States.